{
    "clinical_study": {
        "@rank": "117556", 
        "arm_group": [
            {
                "arm_group_label": "inactivated influenza vaccine (IIV)", 
                "arm_group_type": "Other", 
                "description": "Patients whose provider chooses to administer to them inactivated influenza vaccine (IIV)"
            }, 
            {
                "arm_group_label": "Live attenuated influenza vaccine (LAIV)", 
                "arm_group_type": "Other", 
                "description": "Patients whose provider chooses to administer to them Live attenuated influenza vaccine (LAIV)"
            }
        ], 
        "brief_summary": {
            "textblock": "In this study, the investigators will prospectively assess fever rates in 24-59 month old\n      patients during days 0-10 after administration of inactivated influenza vaccine (IIV) or\n      live attenuated influenza vaccine (LAIV). Children in one of three study sites who receive\n      these vaccines as part of their routine care can enroll in this study if their parent has\n      the ability to receive and send text messages. Children enrolled in this study will be\n      observed for an eleven day period starting on the day of vaccine administration via a series\n      text messages to their parents."
        }, 
        "brief_title": "Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Fever", 
        "condition_browse": {
            "mesh_term": [
                "Fever", 
                "Influenza, Human"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. are 24 through 59 months of age,\n\n          2. have a visit at a study site anytime during the study period,\n\n          3. receive first dose LAIV or IIV in the season,\n\n          4. the parent has a cell phone with text messaging capabilities, and\n\n          5. the parent speaks English or Spanish.\n\n        Exclusion criteria:\n\n          1. any chronic medical condition in the child that precludes receipt of LAIV (except for\n             history of  asthma or a wheezing episode within the past 12 months noted in the\n             medical record),\n\n          2. currently on oral or other systemic steroids or used  in the past month,\n\n          3. currently on inhaled steroids or used in the past 2 weeks,\n\n          4. presence of fever >=100.4 at time of vaccination,\n\n          5. administration of any antipyretic in the 6-hour period prior to vaccination,\n\n          6. stated intent, at time of vaccination, to use prophylactic antipyretics before the\n             development of a fever,\n\n          7. parent only speaks a language other than English or Spanish,\n\n          8. parent's inability to read text messages,\n\n          9. child receiving the second dose of influenza vaccine in the current season."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "59 Months", 
            "minimum_age": "24 Months"
        }, 
        "enrollment": {
            "#text": "3300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01764269", 
            "org_study_id": "AAAK8100"
        }, 
        "intervention": {
            "arm_group_label": [
                "inactivated influenza vaccine (IIV)", 
                "Live attenuated influenza vaccine (LAIV)"
            ], 
            "intervention_name": "text message surveillance for fever", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 1, 2013", 
        "location": [
            {
                "contact": {
                    "email": "krb2@cdc.gov", 
                    "last_name": "Karen Broder, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "Centers for Disease Control and Prevention"
                }, 
                "investigator": [
                    {
                        "last_name": "Karen Broder, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Claudia Vellozzi, MD MPH", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Devindra Sharma, MSN, MPH", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "mss2112@columbia.edu", 
                    "last_name": "Melissa Stockwell, MD MPH", 
                    "phone": "212-342-5732"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia University"
                }, 
                "investigator": [
                    {
                        "last_name": "Melissa Stockwell, MD MPH", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Phil LaRussa, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014", 
        "overall_contact": {
            "email": "mss2112@columbia.edu", 
            "last_name": "Melissa Stockwell, MD MPH", 
            "phone": "212-342-5732"
        }, 
        "overall_contact_backup": {
            "email": "plarussa@columbia.edu", 
            "last_name": "Philip LaRussa, MD", 
            "phone": "212-305-0898"
        }, 
        "overall_official": [
            {
                "affiliation": "Columbia University", 
                "last_name": "Melissa Stockwell, MD MPH", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Columbia University", 
                "last_name": "Philip LaRussa, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "day of vaccination plus 10 more days", 
            "measure": "fever", 
            "safety_issue": "No", 
            "time_frame": "11 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01764269"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Columbia University", 
            "investigator_full_name": "Melissa Stockwell, MD, MPH", 
            "investigator_title": "Assistant Professor of Pediatrics and Population and Family Health", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Columbia University", 
        "sponsors": {
            "collaborator": {
                "agency": "Centers for Disease Control and Prevention", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "Columbia University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}